MSD’s oral cholesterol drug shows promise in late-stage trial
11th November 2025 Uncategorised 0
Enlicitide significantly reduces LDL-C in patients with high cardiovascular risk

More: MSD’s oral cholesterol drug shows promise in late-stage trial
Source: News
